Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00057460Phase 2Completed
A Phase 2 trial of talampanel in epilepsy, sponsored by National Institute of Neurological Disorders and Stroke. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00057460.